维普中文期刊产品整合服务
18篇 您的检索式:作者名="O Cater"
    题名 作者 年代 出处 被引量
1Active versus passive teaching styles:An Empirical Study of Student Learning Outcomes显示文摘Michel N Cater J J Varela O 2009Human resource development quarterly2009,20,4:1
2Compari- son of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late ( five years) after acute myocardial infarction from the incre- mental decrease in end points through aggressive lipid lowering trial 显示文摘Pedersen T R Cater N B Faergeman O 2010Am J Cardiol2010,106,3:1
3Production of cuprous oxide, a solar cell material, by thermal oxidation and a study of its physical and electrical properties显示文摘Musa A O Akomolafe T Cater M J 1998Sol Energy Mater Sol Cells1998,51,:1
4Comparison of atorvas- tatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial in- farction (from the Incremental Decrease in End Points through Ag- gressive Lipid Lowering trial 显示文摘Pedersen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
5Comparison of atorvastatin 80 mg/day versus simvastatin 20 Lo 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering trial) 显示文摘Pedersen TR Cater NB Faergeman O Kastelein JJ Olsson AG Tikkanen M J Holme I Larsen ML Lindahl C Szarek M 2010Am J Cardiol2010,106,3:1
6Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late(five years)after acute myocardial infarction(from the Incremental Decrease in End Points through Aggressive Lipid Lowering trial显示文摘Pedersen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
7Comparison of atorvas- tatin 80 mg/day versus simvastatin 20 to 40 rag/day on frequency of cardiovascular events late(five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering trial显示文摘Pedersen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
8Comparison of atorvastatin 80mg/day versus simvastatin 20 to 40mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering trial)显示文摘Pedersen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
9Using spatial interpolation to construct a comprehensive archive of Australian climate data 显示文摘Stephen J JeffreyJohn O Cater 2001Environmental Modeling & Software2001,16,:1
10Using spatial interpolation to construct a comprehensive archive of Australian climate data显示文摘Steph J Jeffrey John O Cater 2001Environmental Modeling & Software2001,16,:1
11The nelationship of connitive skills performance to activities of daily living in storke patients显示文摘Cater L T Oliveira D O Duponte J 1989American Journal of occupational Therapy1989,42,7:1
12Comparison of atorvasta- tin 80mg,/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late ( five years) after acute myocardial infarc- tion( from the incremental Decrease in End Points through Aggressive Lipid Lowering thai) 显示文摘Pedersen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
13Comparison of atorvastatin 80 rag/day versus simvastatin 20 to 40 rag/ day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental De- crease in End Points through Aggressive Lipid Lowering trial)显示文摘Pederaen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
14Production of cuprous oxide, a solar cell material, by thermal oxidation and a study of its physical and elec-trical properties 显示文摘Musa A O AK Molafe T Cater M J 1998Sol En- ergy Matero Sol Ceils1998,51,34:1
15Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years)after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering[IDEAL] trial)显示文摘Pedersen TR Cater NB Faergeman O 0,,03:1
16Comparison of atorvas-tatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequencyof cardiovascular events late(five years)after acute myocardialinfarction(from the Incremental Decrease in End Points throughAggressive Lipid Loweringtrial显示文摘Pedersen TR Cater NB Faergeman O 2010Am J Cardiol2010,106,3:1
17Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering[IDEAL] trial)显示文摘Pedersen TR Cater NB Faergeman O 0,,:1
18Comparison of atorvastatin 80 mg/d versus simvastatin 20 to 40 mg/d on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the incremental decrease in end points through aggressive lipid lowering [IDEAL]trial)显示文摘Pedersen T R Cater N B Faergeman O 0,,03:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费